Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04274803
Recruitment Status : Withdrawn (no patient enrolled)
First Posted : February 18, 2020
Last Update Posted : June 14, 2021
Sponsor:
Information provided by (Responsible Party):
Ayman S Dawood, MD, Tanta University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : May 31, 2021
Estimated Study Completion Date : May 31, 2021